Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor
- PMID: 12746306
- DOI: 10.1210/en.2002-0113
Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor
Abstract
Dietary restriction (DR) extends life span and improves glucose metabolism in mammals. Recent studies have shown that DR stimulates the production of brain-derived neurotrophic factor (BDNF) in brain cells, which may mediate neuroprotective and neurogenic actions of DR. Other studies have suggested a role for central BDNF signaling in the regulation of glucose metabolism and body weight. BDNF heterozygous knockout (BDNF+/-) mice are obese and exhibit features of insulin resistance. We now report that an intermittent fasting DR regimen reverses several abnormal phenotypes of BDNF(+/-) mice including obesity, hyperphagia, and increased locomotor activity. DR increases BDNF levels in the brains of BDNF(+/-) mice to the level of wild-type mice fed ad libitum. BDNF(+/-) mice exhibit an insulin-resistance syndrome phenotype characterized by elevated levels of circulating glucose, insulin, and leptin; DR reduces levels of each of these three factors. DR normalizes blood glucose responses in glucose tolerance and insulin tolerance tests in the BDNF(+/-) mice. These findings suggest that BDNF is a major regulator of energy metabolism and that beneficial effects of DR on glucose metabolism are mediated, in part, by BDNF signaling. Dietary and pharmacological manipulations of BDNF signaling may prove useful in the prevention and treatment of obesity and insulin resistance syndrome-related diseases.
Similar articles
-
Dietary restriction changes behaviours in brain-derived neurotrophic factor heterozygous mice: role of serotonergic system.Eur J Neurosci. 2006 Oct;24(8):2335-44. doi: 10.1111/j.1460-9568.2006.05094.x. Eur J Neurosci. 2006. PMID: 17074054
-
Anti-obesity and anti-diabetic effects of brain-derived neurotrophic factor in rodent models of leptin resistance.Int J Obes Relat Metab Disord. 2003 May;27(5):557-65. doi: 10.1038/sj.ijo.0802265. Int J Obes Relat Metab Disord. 2003. PMID: 12704399
-
Disruption of a novel regulatory locus results in decreased Bdnf expression, obesity, and type 2 diabetes in mice.Physiol Genomics. 2007 Oct 22;31(2):252-63. doi: 10.1152/physiolgenomics.00093.2007. Epub 2007 Jul 24. Physiol Genomics. 2007. PMID: 17652166
-
Brain-derived neurotrophic factor, food intake regulation, and obesity.Arch Med Res. 2011 Aug;42(6):482-94. doi: 10.1016/j.arcmed.2011.09.005. Epub 2011 Sep 22. Arch Med Res. 2011. PMID: 21945389 Review.
-
Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice.Diabetes Metab Res Rev. 2002 May-Jun;18(3):185-91. doi: 10.1002/dmrr.290. Diabetes Metab Res Rev. 2002. PMID: 12112936 Review.
Cited by
-
BDNF deficiency and young-adult methamphetamine induce sex-specific effects on prepulse inhibition regulation.Front Cell Neurosci. 2013 Jun 12;7:92. doi: 10.3389/fncel.2013.00092. eCollection 2013. Front Cell Neurosci. 2013. PMID: 23781174 Free PMC article.
-
The impact of dietary energy intake on cognitive aging.Front Aging Neurosci. 2010 Mar 8;2:5. doi: 10.3389/neuro.24.005.2010. eCollection 2010. Front Aging Neurosci. 2010. PMID: 20552045 Free PMC article.
-
Effects of Intermittent Fasting on the Circulating Levels and Circadian Rhythms of Hormones.Endocrinol Metab (Seoul). 2021 Aug;36(4):745-756. doi: 10.3803/EnM.2021.405. Epub 2021 Aug 27. Endocrinol Metab (Seoul). 2021. PMID: 34474513 Free PMC article. Review.
-
The association between BDNF levels and risperidone-induced weight gain is dependent on the BDNF Val66Met polymorphism in antipsychotic-naive first episode schizophrenia patients: a 12-week prospective study.Transl Psychiatry. 2021 Sep 4;11(1):458. doi: 10.1038/s41398-021-01585-3. Transl Psychiatry. 2021. PMID: 34482368 Free PMC article. Clinical Trial.
-
_targeting sirtuin-1 in Huntington's disease: rationale and current status.CNS Drugs. 2013 May;27(5):345-52. doi: 10.1007/s40263-013-0055-0. CNS Drugs. 2013. PMID: 23549885 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases